<DOC>
	<DOCNO>NCT02471586</DOCNO>
	<brief_summary>To demonstrate safety efficacy OCT guide strategy stent implantation .</brief_summary>
	<brief_title>ILUMIEN III : OPTIMIZE PCI</brief_title>
	<detailed_description>This prospective , post market , international , multi-center , randomized trial . Patients undergo coronary angiography possibility PCI consent participate study . Patients provide informed consent meet eligibility criterion randomize 1:1:1 undergo PCI either OCT , IVUS , Angiography guidance . All patient undergo baseline post PCI image randomize modality . In addition , Angiography IVUS group undergo blind post-PCI OCT run allow comparison OCT derive minimum stent area ( MSA ) group . After hospital discharge , patient clinical follow-up 30 day 1 year .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>General 1 . Age ≥ 18 year . 2 . Patient indication PCI include : Angina ( stable unstable ) , Silent ischemia ( visually estimate target lesion diameter stenosis ≥70 % , positive noninvasive stress test , fractional flow reserve ( FFR ) ≤0.80 must present ) , NonST segment elevation myocardial infarction ( NSTEMI ) , Recent ST segment elevation myocardial infarction ( STEMI ) ( &gt; 24 hour initial presentation stable ) . 3 . Patients undergo cardiac catheterization possible definite PCI intent stent use noninvestigational metallic drugeluting stent ( DES ) 4 . Signed write informed consent Angiographic inclusion criterion : 1 . The target lesion must locate native coronary artery visually estimate reference vessel diameter ≥2.25 mm ≤3.50 mm . 2 . Lesion length &lt; 40mm Note : Overlapping stent allow General 1 . Estimated creatinine clearance &lt; 30 ml/min use CockcroftGault equation , unless patient dialysis 2 . STEMI within 24 hour initial time presentation first treat hospital , whether transfer facility study hospital . 3 . PCI within 24 hour precede study procedure . 4 . PCI lesion within target vessel within 12 month prior study procedure 5 . Planned use bare metal stent ( BMS ) 6 . Planned use bioresorbable vascular scaffold ( BVS ) 7 . Cardiogenic shock ( defined persistent hypotension ( systolic blood pressure &lt; 90 mm/Hg 30 minute ) require pressor hemodynamic support , include Intraaortic balloon pump ( IABP ) , time procedure . 8 . Mobitz II second degree complete heart block 9 . Malignant ventricular arrhythmia require treatment 10 . Pulmonary edema define patient shortness breath , evidence volume overload physical exam , crepitation physical exam ( &gt; 1/3 lung ) radiographic interstitial alveolar pulmonary edema 11 . Subject intubate . 12 . Known leave ventricular ejection fraction ( LVEF ) &lt; 30 % . 13 . Severe valvular disease ( e.g . severe mitral regurgitation severe aortic stenosis ) 14 . Cerebrovascular accident ( CVA ) transient ischemic attack within past 6 month , permanent neurologic defect attribute CVA . 15 . Presence one comorbidities reduce life expectancy le 12 month may interfere protocol study process . 16 . Known allergy protocolrequired concomitant medication include aspirin ; clopidogrel , prasugrel , ticagrelor ; heparin bivalirudin ; iodinate contrast adequately premedicated . 17 . Patient participate investigational drug device clinical trial reach primary endpoint . 18 . Women pregnant breastfeeding ( woman childbearing potential must negative pregnancy test within one week treatment ) . Angiographic 1 . The presence nonstudy lesion target vessel angiographic diameter stenosis &gt; 50 % , additional target vessel stenosis require PCI either within 12 month study procedure Note : Patients may nonstudy lesion nontarget vessel require PCI . These lesion must treat prior randomization , procedure successful uncomplicated . Alternatively nonstudy lesion nontarget vessel may treat &gt; 24 hour prior &gt; 48 hour study procedure . Successful uncomplicated procedure define &lt; 30 % visually estimate residual diameter stenosis , Thrombolysis In Myocardial Infarction ( TIMI ) Grade 3 flow , dissection ≥ National Heart , Lung Blood Institute ( NHLBI ) type C , perforation , prolong chest pain ST segment elevation depression ( &gt; 30 minute ) , periprocedural myocardial infarction ( MI ) measure creatine kinaseMB ( CKMB ) &gt; 5x upper limit normal ( ULN ) troponin &gt; 35x ULN . 2 . Left main diameter stenosis ≥30 % leave main PCI plan . 3 . Study target lesion bypass graft 4 . Ostial right coronary artery ( RCA ) study target lesion 5 . Chronic total occlusion ( TIMI flow 0/1 ) study target lesion 6 . Bifurcation study lesion plan dual stent strategy 7 . Instent restenosis study target lesion 8 . Any study lesion characteristic resulting expect inability deliver IVUS OCT catheter lesion pre post PCI ( e.g . moderate severe vessel calcification tortuosity )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>